China NMPA Inspection - Guoda (Jilin) Health Technology Co., Ltd. - August 10, 2022

The Jilin Provincial Drug Administration announced its proposal to issue a Cosmetics Production License to Guoda (Jilin) Health Technology Co., Ltd. This administrative action, publicized on August 10, 2022, follows a thorough on-site inspection and subsequent approval by the bureau. The company, located at Office Building No. 7, No. 3999, Aviation Street, China-Korea (Changchun) International Cooperation Demonstration Zone, demonstrated full compliance with the regulatory framework. This framework is guided by the former State Food and Drug Administration's "Notice on Further Improving Current Work Related to Cosmetics Production Licensing." The scope of the proposed license covers the production of General Liquid Unit and Cream and Emulsion Unit products. No violations or deficiencies were identified; instead, the inspection confirmed the company's adherence to all requisite standards for cosmetic manufacturing. As a standard procedural step, the details regarding the proposed license for Guoda (Jilin) Health Technology Co., Ltd. have been publicized for a five-working-day period to allow for public supervision before the final license is issued. This signifies a successful outcome for the company in meeting the operational and quality requirements set by the regulatory body.